![]() ![]() ![]() ![]() There's been such an increase in demand that an FDA database lists the medication's active ingredient, semaglutide, as "currently in shortage." Its manufacturer, Novo Nordisk, says keeping supplies stable is a priority. A landmark clinical trial published in The New England Journal of Medicine in 2021 found that the drug led to a 15% reduction in body weight, on average. That's millions of Americans.Īnd evidence shows the new class of drugs are far more effective than prior obesity medications. Ozempic is approved for diabetes, and Wegovy is for people with obesity who also have weight-related conditions such as high blood pressure or high cholesterol that put them at risk of heart disease. But the injection drug is extremely expensive and when people can't afford to stay on it, they experience rebound weight gain that's hard to stop.įrom TikTok influencers talking it up to celebrities worrying about " Ozempic face," drugs like Wegovy and Ozempic are being touted as weight-loss miracles in a country obsessed with slimness.īut, the drugs aren't intended for cosmetic weight loss. Wegovy has been called "a major breakthrough" given how well it works to reduce body weight. ![]()
0 Comments
Leave a Reply. |